GlucoTrack, Inc. (GCTK)

GlucoTrack Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	4.5	2.33	6.11	9.89	0.42
Cash & Cash Equivalents	4.5	2.33	6.11	9.89	0.42
Cash Growth	93.14%	-61.87%	-38.16%	2259.19%	331.61%
Receivables	0	0	0	0.07	0.07
Inventory	0	0	0	0.28	0.18
Other Current Assets	0.37	0.05	-0.01	-0.01	0.05
Total Current Assets	4.87	2.38	6.11	10.23	0.72
Property, Plant & Equipment	0.03	0.04	0.11	0.32	0.32
Long-Term Investments	0	0	0	0	0.06
Other Long-Term Assets	0.01	0.02	0.05	0.06	0
Total Long-Term Assets	0.04	0.06	0.16	0.38	0.38
Total Assets	4.91	2.44	6.27	10.61	1.1
Accounts Payable	0.84	0.67	0.63	0.87	1.53
Current Debt	0	0	0.02	0.08	0.14
Other Current Liabilities	0.67	0.34	0.23	0.39	0.6
Total Current Liabilities	1.51	1.01	0.88	1.35	2.27
Long-Term Debt	0.2	0.2	0.23	0.28	0.24
Total Long-Term Liabilities	0.2	0.2	0.23	0.28	0.24
Total Liabilities	1.71	1.21	1.11	1.62	2.51
Total Debt	0.2	0.2	0.25	0.36	0.38
Debt Growth	0.51%	-22.00%	-31.13%	-3.97%	124.70%
Retained Earnings	-109.85	-101.9	-97.47	-93.4	-90.7
Comprehensive Income	0.02	0.02	-0.01	0.02	0.12
Shareholders' Equity	3.2	1.23	5.16	8.98	-1.41
Net Cash / Debt	4.31	2.14	5.86	9.52	0.04
Net Cash / Debt Growth	101.59%	-63.57%	-38.43%	23124.39%	-
Net Cash Per Share	1.04	0.69	1.90	3.16	0.02
Working Capital	3.36	1.37	5.22	8.88	-1.55
Book Value Per Share	0.77	0.40	1.67	2.98	-0.59

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).